SeaDragon poised for significant growth

NZX & Media Release 30 May 2014. Link here. Financial results for the year to 31 March 2014 Highlights: • Significant new squalene sales contract demonstrates the benefits of a secure raw material supply • Making good progress on the new refined fish oil plant in Nelson • Financially well positioned with $5.2m of cash on hand […]

AmpliPhi Announces Appointment of New Board Member

RICHMOND, VA, US, LJUBLJANA, SLOVENIA and SYDNEY, AUSTRALIA, May 22, 2014 Link here. AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election […]

AmpliPhi Announces Appointment of New Board Member – Wendy Johnson

Link here. RICHMOND, VA, US, LJUBLJANA, SLOVENIA and SYDNEY, AUSTRALIA, May 22, 2014 –AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election to […]

Avita Medical appoints new Chairman

Australia, 20 May 2014. Link here. Read more about Avita Medical appoints new Chairman

ReCell® Spray-on Skin® demonstrates superior results treating hypopigmentation in aesthetic plastic surgery trial

Link here. Highlights · Clinical study interim results demonstrate ReCell® superiority as treatment for hypopigmentation. · Statistically significant pigment restored in patients’ hypopigmented scars treated with ReCell. · Results support the Company’s commercial strategy for use of ReCell in aesthetic plastic surgery. · Study results delivered at key European conferences, enhancing ReCell industry profile. Northridge, Calif., […]

Union MedTech plc raises £10 million to commercialise and develop REX, a hands-free robotic exoskeleton

May 2, 2014. Link here. Company to be admitted to AIM with a market capitalisation of £25.7 million Union MedTech plc today announces it is to be admitted to the AIM market of the London Stock Exchange with a market capitalisation of £25.7 million. On Admission, the acquisition Union MedTech of REX Bionics Limited (“REX […]